Overall, greater than sixty WNT1/FGF3 targets (related to mitochondria, glycolysis, the EMT, and protein synthesis) that we identified in MCF7-WNT1/FGF3 cells were also transcriptionally elevated in human breast cancer cells in vivo. This evidence concerns the gene FGF3 and breast carcinoma.